sicklecellanemianews3h
Why it’s important to celebrate good care when we receive it
Sickle cell patients often face challenges when implementing their care plans. Columnist Mary Shaniqua describes what good ...
sicklecellanemianews1d
Most patients free of vaso-occlusive crises for years after Casgevy dose
Most sickle cell disease patients who received the gene-editing therapy Casgevy have been free from vaso-occlusive crises for ...
sicklecellanemianews2d
The difficult reality of dealing with invisible sickle cell complications
Invisible complications of sickle cell disease can result in a lack of understanding and proper care, says columnist.
sicklecellanemianews3d
Most SCD patients given Lyfgenia in trials stay free of VOEs: New data
The majority of SCD patients given Lyfgenia in clinical trials remained free of vaso-occlusive events (VOEs) following ...
sicklecellanemianews8d
Kanglin raises $20M to advance sickle cell gene therapy KL003
Kanglin Biotechnology has raised $20 million in financing to advance the development of sickle cell gene therapy KL003.
sicklecellanemianews10d
Trial of gene-editing therapy into SCD’s cause opens in California
Sites in Los Angeles and near San Francisco California are enrolling people with severe SCD for a trial to test a gene ...
sicklecellanemianews14d
I’m learning to manage my anxiety as a sickle cell caregiver
Caregiving is a journey I hold close to my heart, especially as it involves my dear cousin Ada, a vibrant adolescent and a true warrior living with sickle cell disease. Yet I must admit, this journey ...
sicklecellanemianews16d
Blood transfusion is a lifesaving part of my sickle cell management
Columnist Oluwatosin Adesoye addresses some of the myths about blood transfusion and explains why it's important in managing ...